IRS Should Use Tax Law To Combat The Opioid Epidemic

By Kat Allen (May 17, 2019, 4:32 PM EDT) -- State governments and the U.S. Department of Justice are finally targeting pharmaceutical companies for their part in for the opioid epidemic. Purdue Pharma LP, the maker of OxyContin, agreed to pay $270 million to the state of Oklahoma to avoid going to trial on allegations of misleading marketing. Rochester Drug Cooperative Inc. recently agreed to pay the federal government $20 million after it admitted it intentionally violated federal laws by shipping opioids to pharmacies known for illegal distribution. Most recently, a federal jury found Insys Therapeutics executives guilty of racketeering by bribing doctors and misleading insurers about patient needs for the company's fentanyl-based drug....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!